---
title: "Beachbody | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 54.28 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286150295.md"
datetime: "2026-05-12T20:14:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286150295.md)
  - [en](https://longbridge.com/en/news/286150295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286150295.md)
generator: "portal-rs"
---

# Beachbody | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 54.28 M

Revenue: As of FY2026 Q1, the actual value is USD 54.28 M, beating the estimate of USD 51.76 M.

EPS: As of FY2026 Q1, the actual value is USD 0.3, beating the estimate of USD -0.082.

EBIT: As of FY2026 Q1, the actual value is USD 3.812 M.

#### Revenue

-   Total revenue was $54.3 million, compared to $72.4 million in the prior year period.
-   Digital revenue was $33.6 million, compared to $42.9 million in the prior year period.
-   Nutrition and Other revenue was $20.7 million, compared to $28.7 million in the prior year period.
-   Connected Fitness revenue was $0.0 million, compared to $0.8 million in the prior year period, as the sale of bike inventory ceased in the first quarter of 2025.

#### Profitability

-   Gross margin was 71.8%, compared to 71.2% in the prior year period.
-   Total operating expenses were $35.9 million, compared to $55.2 million in the prior year period.
-   Operating income improved by $6.8 million to $3.1 million, compared to an operating loss of - $3.7 million in the prior year period.
-   Net income was $2.3 million, compared to a net loss of - $5.7 million in the prior year period.
-   Adjusted EBITDA was $8.0 million, compared to $3.7 million in the prior year period.
-   Adjusted net income was $2.5 million, compared to a loss of - $5.1 million in the prior year period.

#### Cash Flow

-   Cash used in operating activities for the three months ended March 31, 2026, was - $1.0 million, compared to cash provided by operating activities of $2.3 million in the prior year period.
-   Cash used in investing activities was - $0.7 million, compared to - $0.7 million in the prior year period.
-   Free cash flow was - $1.7 million, compared to $1.6 million in the prior year period.

#### Key Operational Metrics (First Quarter 2026)

-   Digital Subscriptions totaled 0.81 million, down from 1.02 million in the prior year period, representing a decrease of 20.6%.
-   Nutritional Subscriptions totaled 0.06 million, down from 0.08 million in the prior year period, representing a decrease of 25.0%.
-   Total Subscriptions were 0.87 million, a 20.9% decrease from 1.10 million in the prior year period.
-   Average Digital Retention was 95.9%, a decrease of 110 basis points from 97.0% in the prior year period.
-   Total Streams were 17.8 million, a 14.0% decrease from 20.7 million in the prior year period.
-   DAU/MAU was 33.1%, an increase of 60 basis points from 32.5% in the prior year period.
-   Connected Fitness Units Delivered were 0, down from 1.5 thousand in the prior year period, representing a 100.0% decrease.

#### Outlook for The Second Quarter of 2026

-   The Beachbody Company, Inc. anticipates total revenue to be between $46 million and $51 million for the second quarter of 2026.
-   Net income (loss) and adjusted net income (loss) are projected to be between - $3 million and $0 million.
-   Adjusted EBITDA is expected to range from $3 million to $6 million for the quarter ending June 30, 2026.

### Related Stocks

- [BODI.US](https://longbridge.com/en/quote/BODI.US.md)

## Related News & Research

- [Beachbody amends Tiger Finance credit facility, eases covenant tests above USD 22.5 million cash](https://longbridge.com/en/news/295138878.md)
- [SYNSAM: Double-digit sales and profit growth in Q2, with strong margins and expanding subscriptions](https://longbridge.com/en/news/296571574.md)
- [XPLRA: Subscription growth and margin expansion drive improved profitability despite flat revenue](https://longbridge.com/en/news/296303980.md)
- [OpenAI Codex lead points to sub2api as users report shrinking limits](https://longbridge.com/en/news/296611126.md)
- [Can Komzifti's Early Adoption Support Kura Oncology's Next Phase Of Growth?](https://longbridge.com/en/news/296928079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**